Viewing Study NCT00000635

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:23 PM
Ignite Modification Date: 2026-04-09 @ 10:52 PM
Study NCT ID: NCT00000635
Status: COMPLETED
Last Update Posted: 2021-11-02
First Post: 1999-11-02
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Treatment of Acyclovir-Resistant Mucocutaneous Herpes Simplex Disease in Patients With AIDS: Open Label Pilot Study of Topical Trifluridine
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Herpes Simplex View
None HIV Infections View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Bacitracin View
None Polymyxin B View
None Trifluridine View
None AIDS-Related Opportunistic Infections View
None Herpesviridae Infections View
None Drug Evaluation View
None Acquired Immunodeficiency Syndrome View
None Anti-Infective Agents, Local View
None Antiviral Agents View